A GPCR-based yeast biosensor for biomedical, biotechnological, and point-of-use cannabinoid determination
Abstract Eukaryotic cells use G-protein coupled receptors to sense diverse signals, ranging from chemical compounds to light. Here, we exploit…
Abstract Eukaryotic cells use G-protein coupled receptors to sense diverse signals, ranging from chemical compounds to light. Here, we exploit…
Abstract Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver abnormalities and has been linked with metabolic…
Abstract The nonpsychoactive cannabinoid, cannabidiol (CBD), is Food and Dug Administration approved for treatment of two drug-resistant epileptic disorders and…
Abstract Cannabis sativa L. is a plant belonging to the Cannabaceae family, cultivated for its psychoactive cannabinoid (Δ9-THC) concentration or…
Abstract Accumulating data from both human and animal studies suggest that cannabidiol (CBD) may be associated with improved cardiovascular function,…
Abstract The use of Δ8THC is increasing at present across the USA in association with widespread cannabis legalization and the…
Abstract Δ9-Tetrahydrocannabinol is the main psychoactive component of cannabis and cannabidiol is purportedly responsible for many of the medicinal benefits.…
Abstract Background: Nabiximols is a cannabis-based drug to treat spasticity-associated symptoms currently approved for patients with multiple sclerosis only. Cannabinoids…
Abstract Background: The 3M™ Molecular Detection Assay 2—STEC Gene Screen (stx) method is based on gene amplification by the use…
Abstract Background: The 3M™ Molecular Detection Assay 2—Salmonella method is based on real-time loop-mediated isothermal amplification when used with the…